Click here to go to the previous page
Induced Pluripotent Stem (iPS) Cells: Progress and Promise
Program Code:
9208-S-CT
Date:
Sunday, October 10, 2010
Time:
10:30 AM to 12:00 PM
EST
DIRECTOR
:
Elizabeth Read, MD, Professor, University of California, San Francisco
MODERATOR
:
Elizabeth Read, MD, Professor, University of California, San Francisco
SPEAKER
(S):
Marie Csete, MD, PhD, Consultant, self-employed
Linzhao Cheng, PhD, Associate Professor of Medicine, Johns Hopkins University School of Medicine
Mahendra Rao, MD, PhD
IPSC Progress and Promise
Description
Induced pluripotent stem (iPS) cells can be obtained by reprogramming animal or human somatic cells to an embryonic state. iPS cells have been used for drug/toxicology screening and disease modeling, and have potential as a non-controversial stem cell source for patient-specific cellular therapies. This session will review the scientific background, current applications, and future promise of iPS cells.
LEARNER OUTCOMES:
-
Define induced pluripotency.
-
Describe the two general approaches for inducing pluripotency in somatic cells.
-
Examine two or three potential somatic cell sources from which iPS cells have been made.
-
Identify two diseases where iPS cells have been used to model the disease.
CE Category | CE Value |
---|
California Clinical Laboratory Personnel |
1.5 |
California Nurse |
1.8 |
Florida Laboratory Personnel |
1.8 |
General Attendee |
1.5 |
Physician |
1.5 |
Please note: Continuing education (CE) credit is available for online offerings only. Individuals that purchase CD-ROMs will not receive CE credit for the programs they view.